● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
● The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
● The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
● The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
● The stock, which is currently worth 2022 to 0.81 times its sales, is clearly overvalued in comparison with peers.
● Given the positive cash flows generated by its business, the company's valuation level is an asset.
● Over the past year, analysts have regularly revised upwards their sales forecast for the company.
● Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
● For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
● For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
● Analysts covering this company mostly recommend stock overweighting or purchase.
● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
● Over the past four months, analysts' average price target has been revised upwards significantly.
Weaknesses
● The company is not the most generous with respect to shareholders' compensation.
● The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
● The group usually releases earnings worse than estimated.